Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylformamide SCHEMBL28273945 | 0.97 | TSHR (0.64) | TSHR | |
| Dimethylformamide SCHEMBL334823 | 0.93 | — | — | |
| Dimethylformamide SCHEMBL9235032 | 0.88 | TSHR (0.53) | TSHRALDH1A1 | |
| Dimethylformamide SCHEMBL850064 | 0.86 | — | — | |
| Dimethylformamide SCHEMBL8066172 | 0.84 | TSHR (0.56) | TSHR | |
| Dimethylformamide SCHEMBL3627852 | 0.83 | — | — | |
| Dimethylformamide SCHEMBL28266476 | 0.82 | — | — | |
| Dimethylformamide SCHEMBL3867818 | 0.82 | — | — | |
| Dimethylformamide SCHEMBL28003911 | 0.82 | — | — | |
| Dimethylformamide SCHEMBL10812433 | 0.81 | TSHR (0.45) | TSHRUSP2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109053617-A | A kind of industrial production process of radonil | 河南慧锦药业有限公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-102311393-B | Preparation method of sulfadoxine | CHANGSHU JINSHEN MEDICAL CHEMISTRY PRODUCTS CO LTD | 2013-03-13 | — | — | CN | disclosed |
| CN-101249119-B | Compound compound paracetamol and zincgluconate dispersible tablet and method of preparing the same | Hangzhou minsheng pharmaceutical group co ltd | 2011-11-02 | — | — | CN | disclosed |
| CN-101249119-A | Compound compound paracetamol and zincgluconate dispersible tablet and method of preparing the same | HANGZHOU MINSHENG PHARM GROUP (CN) | 2008-08-27 | — | — | CN | disclosed |
| EP-1419155-B1 | PIPERIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 2006-11-08 | — | — | EP | disclosed |
| US-20040198756-A1 | Medicaments | SMITHKLINE BEECHAM PLC (GB) | 2004-10-07 | — | — | US | disclosed |
| EP-1419155-A2 | PIPERIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 2004-05-19 | — | — | EP | disclosed |
| WO-2003010138-A2 | PIPERIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS | SMITHKLINE BEECHAM PLC (GB) | 2003-02-06 | — | — | WO | disclosed |
| US-4101537-A | LUTEINIZING HORMONE RELEASING FACTOR ANTAGONISTS | PARKE, DAVIS & COMPANY (US) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198756-A1 | Medicaments | PIGO, PSAP, CD68 | TSHR 4193/4885USP2 2709/4885ALOX15 1908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.